Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

GH

Guardant Health Inc

Dec 01 • 04:00PM ET

26.33

Dollar change +1.16
Percentage change 4.61	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-4.07	Insider Own	5.40%	Shs Outstand	117.99M	Perf Week	8.85%
Market Cap	3.11B	Forward P/E	-	EPS next Y	-3.39	Insider Trans	-0.03%	Shs Float	111.62M	Perf Month	0.46%
Income	-432.34M	PEG	-	EPS next Q	-0.87	Inst Own	93.49%	Short Float / Ratio	5.68% / 3.48	Perf Quarter	-24.79%
Sales	535.78M	P/S	5.80	EPS this Y	44.12%	Inst Trans	2.05%	Short Interest	6.34M	Perf Half Y	-18.71%
Book/sh	1.94	P/B	13.59	EPS next Y	5.46%	ROA	-24.71%	Target Price	49.22	Perf Year	-49.69%
Cash/sh	9.79	P/C	2.69	EPS next 5Y	-	ROE	-218.88%	52W Range	20.67 - 54.15	Perf YTD	-3.20%
Dividend	-	P/FCF	-	EPS past 5Y	-43.81%	ROI	-27.71%	52W High	-51.38%	Beta	0.90
Dividend %	-	Quick Ratio	5.60	Sales past 5Y	60.55%	Gross Margin	60.38%	52W Low	27.38%	ATR	1.46
Employees	1793	Current Ratio	5.94	Sales Q/Q	21.83%	Oper. Margin	-95.01%	RSI (14)	56.63	Volatility	5.60% 6.24%
Optionable	Yes	Debt/Eq	5.95	EPS Q/Q	53.82%	Profit Margin	-80.69%	Rel Volume	0.58	Prev Close	25.17
Shortable	Yes	LT Debt/Eq	5.83	Earnings	Nov 06 AMC	Payout	-	Avg Volume	1.82M	Price	26.33
Recom	1.24	SMA20	8.23%	SMA50	1.32%	SMA200	-11.85%	Volume	1,054,735	Change	4.61%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-13-23	Upgrade	Raymond James	Mkt Perform → Outperform	$27
Sep-28-23	Initiated	Bernstein	Outperform	$34
Sep-27-23	Upgrade	Piper Sandler	Neutral → Overweight	$40
Jul-05-23	Resumed	JP Morgan	Overweight	$65
May-26-23	Upgrade	Citigroup	Neutral → Buy	$28 → $40
May-05-23	Initiated	UBS	Buy	$40
Mar-09-23	Downgrade	Citigroup	Buy → Neutral	$60 → $33
Jan-05-23	Initiated	Scotiabank	Sector Outperform	$36
Nov-01-22	Downgrade	Piper Sandler	Overweight → Neutral	$65 → $50
Oct-19-22	Initiated	Craig Hallum	Buy	$88
Oct-06-22	Initiated	Stephens	Overweight	$99
Aug-25-22	Initiated	Credit Suisse	Outperform	$80
Jun-03-22	Initiated	Piper Sandler	Overweight	$65
Apr-28-22	Resumed	BTIG Research	Buy	$135 → $115
Feb-24-22	Reiterated	Wells Fargo	Overweight	$150 → $115
Feb-24-22	Reiterated	SVB Leerink	Outperform	$170 → $140
Feb-24-22	Reiterated	Stifel	Buy	$160 → $130
Feb-24-22	Reiterated	Morgan Stanley	Overweight	$125 → $120
Feb-24-22	Reiterated	Cowen	Outperform	$170 → $110
Feb-24-22	Reiterated	Citigroup	Buy	$180 → $120

Show Previous Ratings

Nov-30-23 08:05AM	Guardant Health to present data at San Antonio Breast Cancer Symposium demonstrating utility of liquid biopsy in biomarker identification, therapy selection and residual disease detection (Business Wire)
Nov-29-23 06:41PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
Nov-15-23 04:05PM	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -6.82%
03:00AM	Guardant Health to Appeal Federal District Court Verdict (Business Wire)
Nov-12-23 07:00PM	Guardant Health launches Shield blood-based screening test for colorectal cancer in South Korea (PR Newswire)
11:03AM	Loading…
Nov-08-23 11:03AM	Analyst Report: Guardant Health, Inc. (Morningstar Research) -9.81%
Nov-07-23 10:59AM	Guardant Health, Inc. (NASDAQ:GH) Q3 2023 Earnings Call Transcript (Insider Monkey) -5.41%
08:21AM	Q3 2023 Guardant Health Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-06-23 06:30PM	Guardant Health (GH) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
05:32PM	Guardant Health Inc (GH) Reports 22% Revenue Growth for Q3 2023 (GuruFocus.com)
04:43PM	Guardant Health: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	Guardant Health Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance (Business Wire)
Nov-03-23 08:00AM	Guardant Health to Participate in Upcoming November Investor Conferences (Business Wire) +6.62%
Oct-31-23 08:05AM	Guardant Health, Flatiron Health Announce Integration of Guardant Genomic Profiling Tests Into OncoEMR Platform (Business Wire)
Oct-30-23 05:25AM	11 Best Immunotherapy Stocks To Buy Now (Insider Monkey)
03:45AM	Loading…
Oct-23-23 03:45AM	First results from PEGASUS trial reported at ESMO show promise for use of liquid biopsy to guide adjuvant treatment of colon cancer (Business Wire)
Oct-17-23 09:15AM	Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030 (PR Newswire)
Oct-16-23 04:05PM	Guardant Health to Report Third Quarter 2023 Financial Results on November 6, 2023 (Business Wire)
Oct-11-23 09:53AM	1 Beaten-Down Healthcare Stock to Buy and Hold For 10 Years (Motley Fool)
Oct-10-23 05:18PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
Oct-09-23 02:03AM	14 Best Cancer Stocks To Buy Now (Insider Monkey)
Oct-08-23 07:30AM	Which Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health? (Motley Fool)
Sep-29-23 08:23AM	Guardant Health (GH) Surges 8.8%: Is This an Indication of Further Gains? (Zacks)
Sep-28-23 04:22PM	Why Guardant Health Stock Jumped 15% This Week (Motley Fool) +8.83%
11:25AM	Why Guardant Health Stock Popped Again Today (Motley Fool)
Sep-27-23 12:10PM	Guardant Health Inc (GH): A Deep Dive into Its Performance Potential (GuruFocus.com) +7.05%
11:40AM	Guardant Health (GH): A Potential Value Trap? (GuruFocus.com)
10:00AM	WW upgraded, Macy's downgraded: Wall Street's top analyst calls (The Fly)
Sep-22-23 11:45AM	Guardant Health (GH): A Hidden Value Trap? Unpacking the Risks and Rewards (GuruFocus.com)
Sep-18-23 12:12PM	Guardant Health Inc (GH): A Deep Dive into Its Performance Potential (GuruFocus.com)
06:44PM	Loading…
Sep-15-23 06:44PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
Sep-14-23 12:58PM	Guardant Health (GH) Stock: A Hidden Value Trap? Unpacking the Risks and Rewards (GuruFocus.com)
Sep-09-23 07:31PM	Guardant Health (GH) Stock: A Hidden Value Trap? Unpacking the Risks and Rewards (GuruFocus.com)
Sep-06-23 08:05AM	Guardant Health Receives Coverage for Guardant Reveal from Geisinger Health Plan (Business Wire)
Sep-05-23 08:05AM	Guardant Health Receives Regulatory Approval in Japan for Guardant360® CDx as Companion Diagnostic to ENHERTU® for Treatment of Non-Small Cell Lung Cancer Patients with HER2 Mutations (Business Wire)
Sep-03-23 10:24PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
Sep-01-23 03:46PM	Guardant Health Provides Update on COBRA Study, Restates Confidence in MRD Test (Business Wire) -10.41%
Aug-31-23 04:05PM	Guardant Health to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference (Business Wire)
Aug-30-23 11:41AM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
Aug-22-23 05:51PM	Wall Street Analysts Believe Guardant Health (GH) Could Rally 42.09%: Here's is How to Trade (Zacks)
Aug-17-23 04:05PM	Guardant Health to Host Investor Day on September 7, 2023 (Business Wire)
Aug-10-23 09:53AM	2 Cathie Wood Stocks to Buy and Hold for 10 Years (Motley Fool)
Aug-07-23 03:28PM	Guardant Health Stock Sees Renewed Technical Strength (Investor's Business Daily)
Aug-05-23 06:55AM	Guardant Health, Inc. (NASDAQ:GH) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-04-23 10:45PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research) +6.42%
Aug-03-23 10:46PM	Analyst Report: Guardant Health, Inc. (Morningstar Research)
05:45PM	Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:40PM	Guardant Health: Q2 Earnings Snapshot (AP Finance)
04:05PM	Guardant Health Reports Second Quarter 2023 Financial Results and Increases Revenue Guidance (Business Wire)
Aug-01-23 04:05PM	Guardant resolves pending litigation with Illumina and enters into new agreement to advance long-term commercial partnership and cancer research (Business Wire)
Jul-29-23 12:12AM	Guardant Health (GH) Reports Solid Q2 Results (Insider Monkey)
Jul-21-23 07:33AM	Further weakness as Guardant Health (NASDAQ:GH) drops 3.9% this week, taking three-year losses to 56% (Simply Wall St.)
Jul-20-23 08:05AM	Guardant Health receives first commercial payor coverage for Guardant Reveal test from Blue Cross and Blue Shield of Louisiana (Business Wire)
Jul-19-23 08:52AM	Viking Globals Performance, AUM, and Long-Term Stock Picks (Insider Monkey)
Jul-18-23 09:55AM	Does Guardant Health (GH) Have the Potential to Rally 39.77% as Wall Street Analysts Expect? (Zacks)
Jul-12-23 04:05PM	Guardant Health to Report Second Quarter 2023 Financial Results on August 3, 2023 (Business Wire)
Jul-07-23 06:51AM	What Does Guardant Health, Inc.'s (NASDAQ:GH) Share Price Indicate? (Simply Wall St.)
Jul-05-23 08:05AM	Guardant Health announces reimbursement approval of Guardant360® CDx liquid biopsy test in Japan (Business Wire)
Jun-23-23 03:04PM	Guardant Health Stock Reaches 80-Plus Relative Strength Rating Benchmark (Investor's Business Daily) -5.25%
Jun-14-23 06:39AM	Daily Vickers Top Buyers & Sellers for 06/14/2023 (Argus Research)
Jun-12-23 06:42PM	Analyst Report: Guardant Health, Inc. (Morningstar Research) +5.69%
May-31-23 08:05AM	Guardant Health to present 17 scientific abstracts highlighting contribution of its blood tests and real-world data to advances in precision oncology and cancer screening at 2023 ASCO annual meeting (Business Wire)
May-29-23 09:00PM	Guardant Health Receives Regulatory Approval from Singapore's Health Sciences Authority for Guardant360® CDx blood test for patients with advanced solid cancers (PR Newswire)
May-28-23 09:23AM	Estimating The Intrinsic Value Of Guardant Health, Inc. (NASDAQ:GH) (Simply Wall St.)
May-26-23 08:00AM	Guardant Health to Participate in Upcoming June Investor Conferences (Business Wire)
May-23-23 09:57AM	Stocks to Watch Tuesday: Lowe's, Yelp, PacWest, Broadcom (The Wall Street Journal)
May-22-23 10:03PM	Guardant Health Announces Pricing of Upsized Public Offering of Common Stock (Business Wire)
04:23PM	Guardant Health Announces Proposed Public Offering of Common Stock (Business Wire)
May-19-23 05:50PM	Why Shares of Guardant Health Jumped This Week (Motley Fool)
May-17-23 08:05AM	Guardant Health Secures Coverage From Major US Commercial Health Insurers for Guardant360® Blood Test for Comprehensive Genomic Profiling (Business Wire) +6.61%
May-16-23 08:00AM	Guardant Health Releases Inaugural ESG Report (Business Wire)
May-11-23 04:50PM	Why Guardant Health's Shares Climbed This Week (Motley Fool)
May-10-23 12:43AM	Analyst Report: Guardant Health, Inc. (Morningstar Research) +14.92%
May-09-23 05:45PM	Guardant Health (GH) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Guardant Health Reports First Quarter 2023 Financial Results (Business Wire)
10:15AM	Guardant Health presents additional information from ECLIPSE study at 2023 Digestive Disease Week on the performance of Shield blood test (Business Wire)
May-08-23 04:05PM	Guardant Health Announces Additions to Leadership Team (Business Wire)
May-05-23 08:00AM	Guardant Health Announces ECLIPSE Study Update Call on May 9, 2023 (Business Wire)
May-02-23 10:02AM	Guardant Health (GH) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Apr-27-23 04:05PM	Guardant Health to Participate in the BofA Securities 2023 Healthcare Conference (Business Wire)
Apr-26-23 09:35AM	Down -6.66% in 4 Weeks, Here's Why You Should You Buy the Dip in Guardant Health (GH) (Zacks)
Apr-25-23 08:05AM	Guardant Health and Parker Institute for Cancer Immunotherapy (PICI) launch research collaboration to study connection between cancer biomarkers and immunotherapy treatment response (Business Wire) -7.02%
Apr-21-23 08:05AM	Guardant Health announces new data to be presented at 2023 Digestive Disease Week showcasing the potential of its blood-based technology to detect colorectal cancer (Business Wire)
Apr-20-23 09:55AM	Wall Street Analysts Predict a 123.55% Upside in Guardant Health (GH): Here's What You Should Know (Zacks)
Apr-19-23 04:05PM	Guardant Health to Report First Quarter 2023 Financial Results on May 9, 2023 (Business Wire)
Apr-18-23 08:05AM	Guardant Health Receives Medicare Coverage for Guardant360 Response to Monitor Cancer Patient Response to Immunotherapy (Business Wire)
Apr-11-23 08:05AM	Guardant Health to Present Data From 14 Studies Highlighting Advances in Precision Oncology and Cancer Screening at 2023 AACR Annual Meeting (Business Wire)
Apr-09-23 09:04AM	Guardant Health, Inc. (NASDAQ:GH) insiders placed bullish bets worth US$5.0m in the last 12 months (Simply Wall St.)
Apr-06-23 07:39AM	Guardant Health (GH) Fell on Eclipse Trial Release (Insider Monkey)
Mar-27-23 09:55AM	Here's Why Guardant Health (GH) Looks Ripe for Bottom Fishing (Zacks)
Mar-21-23 10:43AM	Insiders pour millions into these 2 stocks this is what makes them attractive buys (TipRanks)
08:05AM	Guardant Health collaborates with The Ohio State University Comprehensive Cancer Center to study colorectal cancer screening adherence (Business Wire)
Mar-17-23 06:47AM	Daily Vickers Top Buyers & Sellers for 03/17/2023 (Argus Research)
Mar-16-23 06:51AM	Daily Vickers Top Buyers & Sellers for 03/16/2023 (Argus Research) +5.53%
Mar-13-23 06:34AM	In the wake of Guardant Health, Inc.'s (NASDAQ:GH) latest US$536m market cap drop, institutional owners may be forced to take severe actions (Simply Wall St.)
Mar-10-23 08:05AM	Guardant Health submits premarket approval application to the U.S. Food and Drug Administration for Shield blood test (Business Wire) -7.16%
06:55AM	2 Stocks That Could Rebound and Rise 30% or More in 2023 (Motley Fool)
Mar-06-23 09:55AM	How Much Upside is Left in Guardant Health (GH)? Wall Street Analysts Think 75.47% (Zacks) -5.77%
08:50AM	2 Potentially Explosive Growth Stocks Down 30% or More to Buy for the Next Bull Market (Motley Fool)
Feb-27-23 04:05PM	Musa Tariq Joins Guardant Health Board of Directors (Business Wire) +5.09%

Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Palo Alto, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chudova Darya	Chief Technology Officer	Nov 15	Option Exercise	8.80	4,000	35,200	27,683	Nov 16 05:04 PM
POTTER MYRTLE S	Director	Nov 15	Option Exercise	0.00	68	0	7,240	Nov 16 05:02 PM
Joyce Meghan V.	Director	Nov 04	Option Exercise	0.00	66	0	4,456	Nov 06 05:40 PM
Krognes Steve E.	Director	Oct 31	Option Exercise	0.00	154	0	2,468	Nov 01 08:07 PM
POTTER MYRTLE S	Director	Oct 15	Option Exercise	0.00	68	0	7,172	Oct 16 06:28 PM
Joyce Meghan V.	Director	Oct 04	Option Exercise	0.00	67	0	4,390	Oct 05 06:02 PM
Saia John G.	Chief Legal Officer	Oct 01	Option Exercise	0.00	3,895	0	21,817	Oct 02 05:25 PM
Merrill Amelia	SVP, People	Oct 01	Option Exercise	0.00	1,928	0	27,662	Oct 02 05:24 PM
Kalia Kumud	Chief Information Officer	Oct 01	Option Exercise	0.00	6,428	0	14,241	Oct 02 05:22 PM
Freeman Chris	Chief Commercial Officer	Oct 01	Option Exercise	0.00	7,713	0	15,407	Oct 02 05:20 PM
EAGLE CRAIG	Chief Medical Officer	Oct 01	Option Exercise	0.00	6,856	0	11,719	Oct 02 05:18 PM
Chudova Darya	Chief Technology Officer	Oct 01	Option Exercise	0.00	5,356	0	25,536	Oct 02 05:16 PM
Krognes Steve E.	Director	Sep 30	Option Exercise	0.00	155	0	2,314	Oct 02 05:14 PM
Chudova Darya	Chief Technology Officer	Sep 28	Option Exercise	8.80	4,500	39,600	20,180	Sep 29 06:36 PM
POTTER MYRTLE S	Director	Sep 15	Option Exercise	0.00	69	0	7,104	Sep 19 07:07 PM
Bell Michael Brian	Chief Financial Officer	Sep 15	Option Exercise	0.00	1,233	0	9,318	Sep 19 07:04 PM
Kalia Kumud	Chief Information Officer	Sep 12	Sale	32.59	2,125	69,254	7,813	Sep 13 07:11 PM
Merrill Amelia	SVP, People	Sep 09	Option Exercise	0.00	1,047	0	26,097	Sep 11 05:57 PM
Kalia Kumud	Chief Information Officer	Sep 09	Option Exercise	0.00	6,544	0	12,201	Sep 11 05:55 PM
Chudova Darya	Chief Technology Officer	Sep 09	Option Exercise	0.00	2,908	0	16,686	Sep 11 05:52 PM
Joyce Meghan V.	Director	Sep 05	Sale	35.01	100	3,501	4,323	Sep 06 05:46 PM
Joyce Meghan V.	Director	Sep 04	Option Exercise	0.00	66	0	4,423	Sep 06 05:46 PM
Chudova Darya	Chief Technology Officer	Sep 01	Option Exercise	0.00	316	0	13,888	Sep 05 04:59 PM
Saia John G.	Chief Legal Officer	Sep 01	Option Exercise	0.00	263	0	18,315	Sep 05 04:56 PM
Merrill Amelia	SVP, People	Sep 01	Option Exercise	0.00	158	0	25,105	Sep 05 04:54 PM
Kalia Kumud	Chief Information Officer	Sep 01	Option Exercise	0.00	710	0	5,903	Sep 05 04:52 PM
Krognes Steve E.	Director	Aug 31	Option Exercise	0.00	154	0	2,159	Sep 05 04:46 PM
POTTER MYRTLE S	Director	Aug 15	Option Exercise	0.00	68	0	7,035	Aug 16 06:57 PM
Merrill Amelia	SVP, People	Aug 15	Option Exercise	0.00	631	0	25,166	Aug 16 06:56 PM
Joyce Meghan V.	Director	Aug 04	Option Exercise	0.00	66	0	4,357	Aug 07 05:13 PM
Chudova Darya	Chief Technology Officer	Aug 01	Option Exercise	0.00	1,440	0	14,070	Sep 05 04:59 PM
Merrill Amelia	SVP, People	Aug 01	Option Exercise	0.00	1,371	0	25,010	Aug 02 05:53 PM
Krognes Steve E.	Director	Jul 31	Option Exercise	0.00	154	0	2,005	Aug 01 06:08 PM
POTTER MYRTLE S	Director	Jul 15	Option Exercise	0.00	69	0	6,967	Jul 17 04:51 PM
Joyce Meghan V.	Director	Jul 04	Option Exercise	0.00	67	0	4,291	Jul 05 05:01 PM
Krognes Steve E.	Director	Jun 30	Option Exercise	0.00	1,851	0	1,851	Jul 05 04:59 PM
Freeman Chris	Chief Commercial Officer	Jun 15	Option Exercise	0.00	4,879	0	9,040	Jun 16 06:16 PM
Bell Michael Brian	Chief Financial Officer	Jun 15	Option Exercise	0.00	1,233	0	8,512	Jun 16 06:14 PM
POTTER MYRTLE S	Director	Jun 15	Option Exercise	0.00	68	0	6,898	Jun 16 06:12 PM
Joyce Meghan V.	Director	Jun 15	Sale	37.55	2,766	103,863	4,224	Jun 16 06:06 PM
POTTER MYRTLE S	Director	Jun 14	Option Exercise	0.00	5,531	0	6,830	Jun 16 06:12 PM
Kaul Samir	Director	Jun 14	Option Exercise	0.00	5,531	0	11,404	Jun 16 06:08 PM
Joyce Meghan V.	Director	Jun 14	Option Exercise	0.00	5,531	0	6,990	Jun 16 06:06 PM
Gadde Vijaya	Director	Jun 14	Option Exercise	0.00	5,531	0	12,048	Jun 16 06:05 PM
CLARK IAN T	Director	Jun 14	Option Exercise	0.00	6,703	0	8,901	Jun 16 06:03 PM
Kalia Kumud	Chief Information Officer	Jun 09	Buy	32.71	2,981	97,498	5,193	Jun 13 05:42 PM
Joyce Meghan V.	Director	Jun 04	Option Exercise	0.00	66	0	1,459	Jun 05 05:50 PM
Saia John G.	Chief Legal Officer	Jun 01	Option Exercise	0.00	263	0	18,143	Jun 05 05:49 PM
Merrill Amelia	SVP, People	Jun 01	Option Exercise	0.00	158	0	23,694	Jun 05 05:47 PM
Kalia Kumud	Chief Information Officer	Jun 01	Option Exercise	0.00	710	0	2,458	Jun 05 05:45 PM
Chudova Darya	Chief Technology Officer	Jun 01	Option Exercise	0.00	316	0	12,740	Sep 05 04:59 PM
EAGLE CRAIG	Chief Medical Officer	May 15	Option Exercise	0.00	3,718	0	6,149	May 16 05:16 PM
POTTER MYRTLE S	Director	May 15	Option Exercise	0.00	68	0	1,299	May 16 05:12 PM
Joyce Meghan V.	Director	May 04	Option Exercise	0.00	66	0	1,393	May 05 04:54 PM
Saia John G.	Chief Legal Officer	Apr 15	Option Exercise	0.00	7,568	0	21,572	Apr 17 05:43 PM
POTTER MYRTLE S	Director	Apr 15	Option Exercise	0.00	69	0	1,231	Apr 17 05:41 PM
Joyce Meghan V.	Director	Apr 04	Option Exercise	0.00	67	0	1,327	Apr 05 04:58 PM
Bell Michael Brian	Chief Financial Officer	Mar 15	Option Exercise	0.00	4,931	0	8,982	Mar 16 05:30 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Mar 15	Buy	26.15	8,600	224,928	2,049,238	Mar 16 05:24 PM
Eltoukhy Helmy	Co-Chief Executive Officer	Mar 14	Buy	26.33	84,452	2,223,908	2,040,638	Mar 16 05:24 PM
Talasaz AmirAli	Co-Chief Executive Officer	Mar 14	Buy	26.40	8,500	224,376	24,250	Mar 15 06:11 PM
Talasaz AmirAli	Co-Chief Executive Officer	Mar 14	Buy	26.40	8,500	224,376	1,902,345	Mar 15 06:11 PM
Talasaz AmirAli	Co-Chief Executive Officer	Mar 13	Buy	25.66	40,000	1,026,216	1,893,845	Mar 15 06:11 PM
Talasaz AmirAli	Co-Chief Executive Officer	Mar 13	Buy	25.66	40,000	1,026,215	20,000	Mar 15 06:11 PM
Joyce Meghan V.	Director	Mar 04	Option Exercise	0.00	66	0	1,260	Mar 06 05:18 PM
Kalia Kumud	Chief Information Officer	Mar 03	Sale	31.92	6,500	207,466	1,261	Mar 03 04:59 PM
Kalia Kumud	Chief Information Officer	Mar 01	Option Exercise	0.00	711	0	8,007	Mar 03 04:59 PM
Merrill Amelia	SVP, People	Mar 01	Option Exercise	0.00	157	0	23,113	Mar 03 04:57 PM
Saia John G.	Chief Legal Officer	Mar 01	Option Exercise	0.00	263	0	14,112	Mar 03 04:54 PM
Joyce Meghan V.	Director	Feb 04	Option Exercise	0.00	66	0	1,194	Feb 06 05:18 PM
Bell Michael Brian	CHIEF FINANCIAL OFFICER	Jan 15	Option Exercise	0.00	3,309	0	5,371	Jan 17 06:19 PM
POTTER MYRTLE S	Director	Jan 15	Option Exercise	0.00	68	0	1,025	Jan 17 06:16 PM
Kalia Kumud	Chief Information Officer	Jan 07	Option Exercise	0.00	5,375	0	25,867	Jan 09 05:44 PM
Joyce Meghan V.	Director	Jan 04	Option Exercise	0.00	67	0	1,128	Jan 05 06:34 PM
Joyce Meghan V.	Director	Dec 04	Option Exercise	0.00	66	0	1,061	Dec 06 05:24 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GH

Guardant Health Inc

Upgrade your FINVIZ experience